Sarepta Fallout Continues with EU’s Negative Opinion of Elevidys in Ambulatory Patients
The European Union’s health regulatory agency did not endorse approving Elevidys for ambulatory patients with Duchenne muscular dystrophy.
Sarepta Fallout Continues with EU’s Negative Opinion of Elevidys in Ambulatory Patients Read More »
